Zentalis Pharmaceuticals Inc

NASDAQ:ZNTL   3:59:54 PM EDT
65.20
+1.66 (+2.61%)
Earnings Announcements

Zentalis Pharmaceuticals Reports Second Quarter 2021 Financial Results And Operational Update

Published: 08/12/2021 11:47 GMT
Zentalis Pharmaceuticals Inc (ZNTL) - Zentalis Pharmaceuticals Reports Second Quarter 2021 Financial Results and Operational Update.
Zentalis Pharmaceuticals Inc Qtrly Loss per Share $1.34.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.18

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.25

More details on our Analysts Page.